SEC Form S-3/A filed by LMF Acquisition Opportunities Inc. (Amendment)
|
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
|
Delaware
|
85-3681132
|
|
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
|
|
Incorporation or Organization)
|
Identification No.
|
Denver, CO 80216
(844) 427-8100
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Chief Executive Officer
3513 Brighton Blvd., Suite 410
Denver, CO 80216
(844) 427-8100
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
|
Large, accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|
Emerging growth company
|
☒
|
| • |
our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March
30, 2023, and as amended on Form 10-K/A, filed with the SEC on April 28, 2023;
|
| • |
our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023, filed with the SEC on May 15, 2023, August 14, 2023,
and November 14, 2023, respectively;
|
| • |
our Current Reports on Form 8-K filed with the SEC on January 9, 2023 (with respect to Item
8.01 only), February 9, 2023 (with respect to Item 8.01 only), February 15, 2023 (with respect to Item 8.01 only), March 16, 2023 (with respect to Items 1.01, 2.03, and 3.02 only), May 9, 2023 (with respect to Item 8.01 only), June 9, 2023, June 16, 2023, June 30, 2023, August 2, 2023
(with respect to Item 4.01 only), August 8, 2023 (with respect to Items 1.01, 2.03 and 3.02 only), August 30, 2023 (with respect to Items 1.01, 2.03, and 3.02 only), September 8, 2023, September
20, 2023 (with respect to Item 5.03 only), September 26, 2023, October 3, 2023 (with respect to Item 8.01 only), October 30, 2023 (with respect to Item 8.01 only), November 27, 2023, and November 29, 2023;
and
|
| • |
the description of our Common Stock which is registered under Section 12 of the Exchange Act, in our registration statement on Form 8-A, filed on January 22, 2021, including any amendments or reports filed for the purposes of updating this description.
|
|
SEASTAR MEDICAL HOLDING CORPORATION
|
||
|
By:
|
/s/ Eric Schlorff
|
|
|
Name:
|
Eric Schlorff
|
|
|
Title:
|
Chief Executive Officer
|
|
|
Name
|
Title
|
Date
|
|
/s/ Eric Schlorff
|
Chief Executive Officer and Director
|
December 7, 2023
|
|
Eric Schlorff
|
(Principal Executive Officer)
|
|
|
/s/ *
|
Interim Chief Financial Officer
|
December 7, 2023
|
|
Caryl Baron
|
(Principal Financial and Accounting Officer)
|
|
|
/s/ *
|
Chairman of the Board of Directors
|
December 7, 2023
|
|
Rick Barnett
|
||
|
/s/ *
|
Director
|
December 7, 2023
|
|
Kenneth Van Heel
|
||
|
/s/ *
|
Director
|
December 7, 2023
|
|
Andres Lobo
|
||
|
/s/ *
|
Director
|
December 7, 2023
|
|
Allan Collins
|
||
|
/s/ *
|
Director
|
December 7, 2023
|
|
Bruce Rodgers
|
||
|
/s/ *
|
Director
|
December 7, 2023
|
|
Richard Russell
|
||
|
* By: /s/ Eric Schlorff
|